Cargando…
The Effect in Renal Function and Vascular Decongestion in Type 1 Cardiorenal Syndrome Treated with Two Strategies of Diuretics, a Pilot Randomized Trial
AIM: The main treatment strategy in type 1 cardiorenal syndrome (CRS1) is vascular decongestion. It is probable that sequential blockage of the renal tubule with combined diuretics (CD) will obtain similar benefits compared with stepped-dose furosemide (SF). METHODS: In a pilot double-blind randomiz...
Autores principales: | Chávez-Iñiguez, Jonathan S., Ibarra-Estrada, Miguel, Sánchez-Villaseca, Sergio, Romero-González, Gregorio, Font-Yañez, Jorge J., De la Torre-Quiroga, Andrés, de Quevedo, Andrés Aranda-G, Romero-Muñóz, Alexia, Maggiani-Aguilera, Pablo, Chávez-Alonso, Gael, Gómez-Fregoso, Juan, García-García, Guillermo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722345/ https://www.ncbi.nlm.nih.gov/pubmed/34979962 http://dx.doi.org/10.1186/s12882-021-02637-y |
Ejemplares similares
-
Decongestion: Diuretics and other therapies for hospitalized heart failure
por: Vazir, Ali, et al.
Publicado: (2016) -
How to interpret serum creatinine increases during decongestion
por: Chávez-Íñiguez, Jonathan S., et al.
Publicado: (2023) -
Loop diuretics in acute heart failure: beyond the decongestive relief for the kidney
por: Palazzuoli, Alberto, et al.
Publicado: (2015) -
Venous Excess Doppler Ultrasound: A Visual Guide to Decongestion in Cardiorenal Syndrome
por: Gudlawar, Sirisha, et al.
Publicado: (2023) -
Cardiorenal syndrome: Resistant to diuretics, sensitive to ultraflitration
por: Aundhakar, Swati C., et al.
Publicado: (2012)